Cosan is a Brazilian energy and logistics investment holding company with no own operation: its income comes from investment dividends. The portfolio includes Raízen (bioenergy and fuels), Rumo (rail logistics), Compass (natural gas, listed in 2026), Moove (lubricants) and Radar (farmland), as well as a stake in Vale. In 2025 revenue, Compass accounts for about 41%, Rumo 34% and Moove 23%; about 86% of revenue comes from Brazil. Rubens Ometto Silveira Mello controls holding companies such as Aguassanta, Queluz and Vertiz, with about 41% of common shares. In 2025, Cosan received funding from BTG Pactual and Perfin, via Vertiz, in an offer that raised R$ 10.5 billion.
Market capitalization, or "market cap", is the aggregate market value of a company represented in a dollar amount. Since it represents the “market” value of a company, it is computed based on the current market price (CMP) of its shares and the total number of outstanding shares.
Enterprise value (EV) measures a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt and any cash or cash equivalents on the company's balance sheet.
The enterprise value-to-revenue multiple (EV/R) is a measure of the value of a stock that compares a company's enterprise value to its revenue. EV/R is one of several fundamental indicators that investors use to determine whether a stock is priced fairly. The EV/R multiple is also often used to determine a company's valuation in the case of a potential acquisition. It's also called the enterprise value-to-sales multiple.
The enterprise value to earnings before interest, taxes, depreciation, and amortization ratio (EV/EBITDA) compares the value of a company—debt included—to the company's cash earnings less non-cash expenses. It's best to use the EV/EBITDA metric when comparing companies within the same industry or sector. Typically, when evaluating a company, an EV/EBITDA value below 10 is seen as healthy.
It follows the same logic as the EV/EBITDA indicator, but instead of EBITDA, EBIT is used, which considers non-cash D&A expenses in the company's operating result.
...and much more!